SCHEMBL3846783

SCHEMBL3846783

O=C(O)N(c1ccn[nH]1)C1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
MITF O75030 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
PAX8 Q06710 1/20 0.40
TRPM8 Q7Z2W7 5/20 0.39
LMNA P02545 3/20 0.38
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HCAR2 Q8TDS4 1/20 0.37
S1PR1 P21453 1/20 0.34
ATM Q13315 1/20 0.34
GAA P10253 1/20 0.34
THRB P10828 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22412884 0.73 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2NPC1KDM4EMEN1
SCHEMBL28377697 0.73 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2NPC1KDM4EMEN1
SCHEMBL6215102 0.69 KDM4E (0.68) ALDH1A1SMN1; SMN2NPC1KDM4EMEN1
SCHEMBL11407980 0.67 MEN1 (0.65) ALDH1A1SMN1; SMN2NPC1KDM4EMEN1
SCHEMBL28210239 0.67 HCAR2 (0.45) SMN1; SMN2NPC1RAB9ATRPM8LMNA
SCHEMBL27629277 0.66 NPC1 (0.54) ALDH1A1SMN1; SMN2NPC1KDM4EMEN1
SCHEMBL1690729 0.66 RAB9A (0.50) ALDH1A1SMN1; SMN2NPC1KDM4EMEN1
SCHEMBL22412717 0.66 TRPM8 (0.63) ALDH1A1SMN1; SMN2NPC1KDM4EMEN1
SCHEMBL15414899 0.66 TRPM8 (0.39) ALDH1A1SMN1; SMN2NPC1KDM4EMEN1
SCHEMBL22496063 0.66 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2NPC1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 WO disclosed